Literature DB >> 1482674

Type II interferon may be a potential hazardous therapeutic agent during pregnancy.

S Vassiliadis, I Athanassakis.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1482674     DOI： 10.1111/j.1365-2141.1992.tb06967.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Pregnancy after treatment with hydroxyurea in a patient with primary thrombocythaemia and a history of recurrent abortion.

Authors:  K I Cinkotai; P Wood; P Donnai; J Kendra
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

3.  Analysis of the IFN-gamma-induced signal transduction pathway in fetal rejection.

Authors:  I Athanassakis
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

4.  An increase in nitric oxide produced by rat peritoneal neutrophils is not involved in cell apoptosis.

Authors:  I M Fierro; C Barja-Fidalgo; R M Canedo; F Q Cunha; S H Ferreira
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.